Gateway for Cancer Research

When Joe was diagnosed with a genetic mutation impacting his blood cells, fear and uncertainty filled his life. But thanks to a clinical trial funded by Gateway, everything has changed. Through Dr. Bolton's trial at Washington University in St. Louis, Joe has been able to receive life-saving treatment close to home. 'Gateway's ability to provide the funding for this trial has saved my life. Today, his blood levels are normal, his hope is restored, and he looks forward to seeing his daughter get married and sharing many more years with his loved ones. https://lnkd.in/gGz87RjB #BeAGateway #CancerResearch #GatewayForCancerResearch #PatientStories

Ever wonder how Gateway for Cancer Research decides which clinical trials to fund? It's all about rigorous review and a relentless focus on our mission. Our Research and Grants Committee leaves no stone unturned, evaluating each proposal for scientific merit, financial responsibility, and alignment with our goal to transform cancer care. Your donations are in good hands, and are helping to fuel the research that will change lives. https://lnkd.in/gbrYv_9x #BeAGateway #CancerResearch #GatewayForCancerResearch #FundingTheCure

Deaths attributed to brain cancer have decreased by 12.5% since 1991, and the 5-year survival rate has seen a relative 10% increase. Thanks to donors like you, Gateway has invested nearly $15 million (12.7% of its research funding) in brain cancer clinical trials since 1991. https://lnkd.in/gsh2zqfV #BeAGateway #CancerResearch #GatewayForCancerResearch

Phase I and Phase II clinical trials ignite brilliant ideas for new treatments. They bring innovation and fearless determination together and transform the way we fight cancer. That's where you come in! This Giving Tuesday, your gift will bring a potentially lifesaving treatment one step closer to patients who have run out of options. You'll be the catalyst for a breakthrough that could change everything. Be the spark that ignites a cancer breakthrough! Click the link below to learn more. https://lnkd.in/gQKPBpvJ #BeAGateway #CancerResearch #GatewayForCancerResearch

Thanksgiving—the season of gratitude, warmth, and cherished time with loved ones. As we gather, we reflect on the moments that truly matter. To our donors, your generosity is the reason many men, women, and children get to experience the joy of Thanksgiving. From the bottom of our hearts, thank you for making a difference! May this holiday infuse your heart with joy, your spirit with inspiration, and your life with abundance. From our Gateway family to yours, Happy Thanksgiving! 🦃

Lung cancer has seen a 96% relative increase in the 5-year survival rate since 1991. Despite being the leading cause of cancer death, there has been a nearly 50% drop in lung cancer deaths since 1991. A Gateway-funded clinical trial is the only known ongoing study of a personalized vaccine used in first-line therapy for small-cell lung cancer. https://lnkd.in/gkJ6jSGY #BeAGateway #CancerResearch #GatewayForCancerResearch

Today we're highlighting the exceptional work of our Director of Clinical Science, Hunter Patton-Gentert, PharmD. 'My role can be summed up in one line: To find the most impactful, innovative, and evidence-based investigator-initiated oncology clinical trials.' This privilege allows him to collaborate with some of the brightest minds in oncology research to bring novel therapies and treatment options to patients today——ultimately changing the cancer care paradigm for tomorrow. https://lnkd.in/gEVg2ahs

The power of a dedicated mission focused team! We surpassed $3 million raised at the 33rd annual Gateway for Cancer Research Cures Gala fueling early phase clinical trials that bring hope to cancer patients and families worldwide. I’m proud to work alongside this passionate group of change-makers Delora Senft, Hunter Patton-Gentert, PharmD, Jeremy Alonso, Daisy Orozco, Kari Watts, Kim Schwartz, Natalia Mihilli and Kristine Burnett. Let's keep pushing the boundaries of what's possible in cancer research. Thank you for your tireless efforts! #cancerresearch #clinicaltrials #alwaysandonlyaboutthepatient

The 21st International Conference of The Society for Integrative Oncology aimed to establish evidence-based standards for integrative cancer therapies. It highlighted the latest research and innovative methodologies to improve patient quality of life. The goal was to inspire clinicians to update their practices and researchers to explore new avenues.   We were honored to have our Director of Clinical Science, Hunter Patton-Gentert, PharmD on the panel of the SIO workshop - “Getting your Integrative Oncology Proposals Funded: Practical Advice from Experts and Funders”. Representing Gateway for Cancer Research, Hunter provided valuable insight into the grant process and shared best practices for moving early career investigators ideas forward.   “I was grateful for the chance to speak on a panel at The Society for Integrative Oncology 2024 Conference, educating early career investigators about opportunities at Gateway, as well as how to enhance their study designs to promote effective and meaningful investigation of integrative oncology care. By doing so, we will continue to support the most impactful, evidence-based, and patient-centered oncology clinical trials.” Hunter Patton-Genert, PharmD Director of Clinical Science Gateway for Cancer Research

Treanor Baring was diagnosed with triple-negative stage III breast cancer. When medication-induced severe colitis threatened to end her cancer treatment, her hopes of beating triple-negative stage III breast cancer diminished. After being in a Gateway-funded clinical trial at MD Anderson Cancer Center and being able to continue her cancer treatment, she is finally cancer-free. #BeAGateway #CancerResearch #GatewayForCancerResearch #PatientStories